Twist Bioscience (TWST) Change in Cash (2017 - 2026)

Twist Bioscience has reported Change in Cash over the past 10 years, most recently at -$26.1 million for Q1 2026.

  • Quarterly Change in Cash fell 135.18% to -$26.1 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was -$88.1 million through Mar 2026, down 164.8% year-over-year, with the annual reading at -$43.7 million for FY2025, 27.34% up from the prior year.
  • Change in Cash was -$26.1 million for Q1 2026 at Twist Bioscience, up from -$34.4 million in the prior quarter.
  • Over five years, Change in Cash peaked at $216.0 million in Q1 2022 and troughed at -$61.2 million in Q4 2022.
  • The 5-year median for Change in Cash is -$12.9 million (2024), against an average of -$4.0 million.
  • Year-over-year, Change in Cash soared 327.39% in 2022 and then tumbled 1396.73% in 2024.
  • A 5-year view of Change in Cash shows it stood at -$61.2 million in 2022, then skyrocketed by 67.03% to -$20.2 million in 2023, then soared by 74.84% to -$5.1 million in 2024, then tumbled by 578.89% to -$34.4 million in 2025, then rose by 24.12% to -$26.1 million in 2026.
  • Per Business Quant, the three most recent readings for TWST's Change in Cash are -$26.1 million (Q1 2026), -$34.4 million (Q4 2025), and -$18.5 million (Q3 2025).